Gujarat High Court ruled that reassessment beyond four years is invalid when no new material or failure of disclosure exists, terming it a mere change of ...
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.
New details are still coming to light after the release of 20,000 Jeffrey Epstein files, which came after an initial leak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback